Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Autoimmune diseases, including systemic lupus erythematosus (SLE) , are associated with dysregulated T and B cell responses. AMG 570 is a bi-specific molecule that targets T cell and B cell activity by inhibiting inducible costimulatory ligand (ICOSL) and B cell activator (BAFF). Dual inhibition of ICOSL and BAFF was more effective than single inhibition in improving the incidence and severity of arthritis in the mouse CIA model as well as reducing anti-DSDNA IgG, delayed albuminuria, and improving survival in the NZB/NZW lupus model. In addition, a single dose of AMG 570 was safe and well tolerated, and showed pharmacodynamic activity consistent with the inhibition of ICOSL and BAFF.